{"id":"W4353086468","doi":"10.54097/hset.v36i.5700","title":"The usage of Pembrolizumab in Metastatic Urothelial Carcinoma","year":2023,"lang":"en","type":"article","venue":"Highlights in Science Engineering and Technology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Pembrolizumab; Metastatic Urothelial Carcinoma; Medicine; Oncology; Chemotherapy; Bladder cancer; Internal medicine; Cancer; Immunotherapy; Cisplatin; Carcinoma; Adverse effect; Immune checkpoint; Urothelial carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003766104,0.0001435498,0.0002790864,0.0003707134,0.0002286629,0.0002843647,0.0001575683,0.0003322008,0.001204884],"category_scores_gemma":[0.0004393428,0.00004977132,0.0003197177,0.000319686,0.0001453668,0.0003424219,0.0001844652,0.0005903142,0.0002780808],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003272987,"about_ca_system_score_gemma":0.0003190703,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006565881,"about_ca_topic_score_gemma":0.001446256,"domain_scores_codex":[0.9998236,0.00005738229,0.00002282458,0.00002616252,0.00004250311,0.00002747187],"domain_scores_gemma":[0.9998844,0.00002812363,0.00003385267,0.000007952283,0.00002666741,0.00001896896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0009081745,0.0003842489,0.008108691,0.002149377,0.0001481549,0.001672831,0.0001792411,0.0002904952,0.0409255,0.00230452,0.01122333,0.9317054],"study_design_scores_gemma":[0.0004624749,0.005179736,0.08047114,0.002213007,0.0009487705,0.0295554,0.0003984601,0.001694011,0.07199656,0.003346122,0.8036696,0.00006481758],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1425176,0.8261727,0.003592375,0.007308121,0.0007418519,0.0001049543,0.0001598579,0.00007943156,0.01932308],"genre_scores_gemma":[0.6401119,0.3440584,0.003744297,0.002895799,0.001039615,0.000106222,0.0002463692,0.00001604116,0.007781327],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.001204884,"threshold_uncertainty_score":0.004030704,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01249795525555912,"score_gpt":0.2631294578952759,"score_spread":0.2506315026397168,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}